Eylea and Heart rate decreased - a phase IV clinical study of FDA data

Summary:

Heart rate decreased is reported as a side effect among people who take Eylea (aflibercept), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prednisone, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Heart rate decreased when taking Eylea. It is created by eHealthMe based on reports of 27,819 people who have side effects when taking Eylea from the FDA, and is updated regularly.

What is Eylea?

Eylea has active ingredients of aflibercept. It is often used in macular degeneration. eHealthMe is studying from 27,868 Eylea users. Check the latest studies of Eylea.

What is Heart rate decreased?

Heart rate decreased is found to be associated with 1,545 drugs and 1,599 conditions by eHealthMe. Check the latest studies of Heart rate decreased.

On Jul, 24, 2026

27,819 people reported to have side effects when taking Eylea.
Among them, 20 people (0.07%) have Heart rate decreased.

Among these 20 people:

How long have people been on Eylea when they have Heart rate decreased? *

What is the gender of people who have Heart rate decreased when taking Eylea? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Heart rate decreased when taking Eylea? *

What are other drugs people take besides Eylea? *

What are other side effects people have besides Heart rate decreased? *

Oedema Peripheral (superficial swelling): 10 people, 50.00%
Haemorrhage (bleeding): 10 people, 50.00%
Infusion Site Extravasation (flow of (blood or lymph) from infusion site): 9 people, 45.00%
Blood Pressure Systolic Increased: 9 people, 45.00%
Headache (pain in head): 9 people, 45.00%
Peripheral Swelling: 9 people, 45.00%
Infusion Site Pain: 9 people, 45.00%
Pigmentation Disorder (disturbances of human skin colour): 9 people, 45.00%
Joint Swelling: 9 people, 45.00%
Inflammation: 9 people, 45.00%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 45.00%
Blood Pressure Abnormal: 9 people, 45.00%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 15.00%
Age-Related Macular Degeneration: 3 people, 15.00%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 10.00%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.00%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 1 person, 5.00%
High Blood Cholesterol: 1 person, 5.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%
Thyroid Diseases: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eylea and have Heart rate decreased?

- Check whether Heart rate decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eylea:

Eylea (27,868 reports)

Browse all side effects of Eylea:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart rate decreased:

Heart rate decreased (1,545 drugs)

Browse all the conditions that are associated with Heart rate decreased:

Heart rate decreased (1,599 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aflibercept (the active ingredients of Eylea) and Eylea (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.